Drug discovery via human-derived stem cell organoids
Patient-derived cell lines and animal models have proven invaluable for the understanding of human intestinal diseases and for drug development although both inherently comprise disadvantages and caveats. Many genetically determined intestinal diseases occur in specific tissue microenvironments that...
Saved in:
Main Authors: | Fangkun Liu (Author), Jing Huang (Author), Bo Ning (Author), Zhixiong Liu (Author), Shen Chen (Author), Wei Zhao (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2016-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Gastrointestinal tract organoids as novel tools in drug discovery
by: Li Zhou, et al.
Published: (2024) -
Progress of induced pluripotent stem cell (iPSC)-derived renal organoids in clinical application
by: Na Ning, et al.
Published: (2024) -
Immune Checkpoint in Glioblastoma: Promising and Challenging
by: Jing Huang, et al.
Published: (2017) -
Organoids and Microphysiological Systems: New Tools for Ophthalmic Drug Discovery
by: Jing Bai, et al.
Published: (2020) -
Stem Cell Derived Organoids in Human Disease and Development
by: Stefan Liebau, et al.
Published: (2019)